Third Annual Controversies in Hematologic Malignancies Symposium

Milwaukee, WI US
March 8, 2014

For the past decade, cancer knowledge and treatments has changed dramatically. Two of the hematologic malignancies that stand out in diagnostic and therapeutic advances are chronic myeloid leukemia and multiple myeloma.  Controversies regarding timing of treatment, type of treatment, criteria for progression and response exist.  We plan to focus our meeting in meeting in these two malignancies to update our audience in the new recommendations and future directions of care.

A review of common hematology topics, nursing and pharmacy will also be provided in breakout sessions.

Target Audience

Physicians, Physician Assistants, Nurse Practitioners, Pharmacists, Registered Nurses

Learning Objectives

  • Recognize the laboratory tests and their use in Chronic Myeloid Leukemia
  • Describe the guidelines for initial and subsequent therapy in Chronic Myeloid Leukemia according to response criteria
  • Select the initial therapy for Multiple Myeloma according to risk stratification
  • Identify the role for autologous transplant in Multiple Myeloma
  • Review the most up to date evidence in the treatment of Multiple Myeloma
Additional information

CME Coordinator Contact Information

Name: 
Alex Leahy and Kayla Becker-Botero
Phone Number: 
+1 (414) 805-4600
Course summary
Available credit: 
  • 5.50 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 5.50 Hours of Participation
    Hours of Participation credit.
Course opens: 
01/02/2014
Course expires: 
05/10/2014
Event starts: 
03/08/2014 - 7:30am
Event ends: 
03/08/2014 - 3:30pm
Cost:
$0.00
Hilton Milwaukee City Center
509 West Wisconsin Ave
Milwaukee, WI 53203
United States

Hilton Milwaukee City Center
509 West Wisconsin Ave
Milwaukee, WI 53203

Special Room Rates:

2 Double Beds (Rates from 129.00 USD/Night) Tax 15.10%/night
1 King Bed      (Rates from 129.00 USD/Night) Tax 15.10%/night
A special overnight parking rate of $18 is available for our registered guests.

Group Name: Medical College of WI - Hematology
Group Code: MCWH
Check In: 07-MAR-2014
Check-Out: 09-MAR-2014
Phone Number: 414-390-8249

Room rate is available until February 5th or until sold out.

http://www.hilton.com/en/hi/groups/personalized/M/MKEMHHF-MCWH-20140307/index.jhtml?WT.mc_id=POG

Froedtert and Medical College of Wisconsin Faculty and Staff

Carlos Arce-Lara, MD Co-Program Director
Marcelo Pasquini, MD, MS Co-Program Director
Ehab Atallah, MD
Kayla Becker-Botero 
Michael Burke, MD
Timothy Fenske, MD
Parameswaran Hari, MD, MS
Alexandra Harrington, MD
​Stacie Lahr, RN, OCN
Alex Leahy
Julie Maher, CPhT
Rebecca Martin, BSN RN OCN
Laura C. Michaelis, MD
Emily Richter, MSN, RN, ACNS-BC, AOCNS
Mindy Waggoner, Pharm.D, BCOP

Guest Speakers

Michael Deininger, MD
Adjunct Professor, Oncological Sciences
Professor and Division Chief
University of Utah School of Medicine

Paul G. Richardson, MD
RJ Corman Professor of Medicine, Harvard Medical School
Clinical Director, Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute

All persons in control of content have NO relevant relationships to disclose with the exception of:

Ehab Atallah, MD-Novartis, BMS, Ariad, Pfizer
Timothy Fenske, MD-Seattle Genetics
Marcelo Pasquini, MD, MS-Miltenyi-Biotec
Paul Richardson, MD-Millennium, Celgene, Johnson & Johnson, Bristol Myers Squibb, Novartis, Genmab

In accordance with the ACCME® standards for Commercial Support # 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of resolution process and resolved.

Available Credit

  • 5.50 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 5.50 Hours of Participation
    Hours of Participation credit.

Accreditation Period

Course opens: 
01/02/2014
Course expires: 
05/10/2014

Price

Cost:
$0.00
Please login or register to take this course.